- The United States is grappling with a rare and dangerous fungal infection known as Candida auris, with four recent cases reported in Washington state.
- This concerning development has raised alarms among doctors due to the infection’s high fatality rate, drug resistance, and its propensity to spread easily in healthcare facilities.
Spread and Concerns
The first confirmed case was reported on January 10, and the public health agency for Seattle and King County disclosed three additional instances of Candida auris infection last week. This fungus particularly targets individuals with weakened immune systems and exhibits resistance to several common antifungal drugs. Patients in hospitals using feeding tubes, breathing tubes, or catheters are at higher risk of contracting the infection.
Symptoms and Severity
Candida auris can cause infections in various parts of the body, including the bloodstream, open wounds, and ears, according to the Centers for Disease Control (CDC). The severity and symptoms vary depending on the site of infection. Unlike bacterial infections that may display typical signs, Candida auris infections lack a specific set of identifiable symptoms.
Transmission and Precautions
The CDC warns that individuals colonized with Candida auris can transmit the infection to surfaces or objects they touch, leading to further transmission to other patients. In cases of colonization or infection, patients should be isolated in separate rooms. Thorough cleaning with disinfectant products is crucial, and caregivers must wear gloves and gowns. To prevent further spread, people should use alcohol-based hand sanitizer or wash their hands before entering and leaving the patient’s room and after contact with the patient or their medical devices.
Origins and Global Impact
Discovered in Japan 15 years ago, Candida auris has witnessed a surge in cases worldwide. In 2022 alone, it infected 2,377 people, a significant increase from 53 cases in 2016. The rapid spread across most US states and 40 countries has prompted the CDC and World Health Organization to classify it as a growing threat. In 2021, the fungus infected 1,471 people, according to CDC data. The global concern underscores the need for vigilance and preventive measures to curb the further spread of this rare fungal infection.
Did you subscribe to our daily Newsletter?
It’s Free! Click here to Subscribe
Source: Financial Express
